Logo image of AVR

ANTERIS TECHNOLOGIES GLOBAL (AVR) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:AVR - US03675P1021 - Common Stock

4.67 USD
+0.13 (+2.86%)
Last: 12/5/2025, 8:04:01 PM
4.67 USD
0 (0%)
After Hours: 12/5/2025, 8:04:01 PM
Fundamental Rating

2

Overall AVR gets a fundamental rating of 2 out of 10. We evaluated AVR against 188 industry peers in the Health Care Equipment & Supplies industry. AVR may be in some trouble as it scores bad on both profitability and health. AVR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year AVR has reported negative net income.
AVR had a negative operating cash flow in the past year.
AVR Yearly Net Income VS EBIT VS OCF VS FCFAVR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 -20M -40M -60M

1.2 Ratios

The Return On Assets of AVR (-440.09%) is worse than 97.87% of its industry peers.
AVR has a worse Return On Equity (-2269.93%) than 88.30% of its industry peers.
Industry RankSector Rank
ROA -440.09%
ROE -2269.93%
ROIC N/A
ROA(3y)-145.5%
ROA(5y)N/A
ROE(3y)-232.78%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AVR Yearly ROA, ROE, ROICAVR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 -100 -200 -300

1.3 Margins

With a decent Gross Margin value of 67.94%, AVR is doing good in the industry, outperforming 72.87% of the companies in the same industry.
AVR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 67.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AVR Yearly Profit, Operating, Gross MarginsAVR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 0 -500 -1K -1.5K -2K -2.5K

More info and screens

2

2. Health

2.1 Basic Checks

AVR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AVR remains at a similar level compared to 1 year ago.
The debt/assets ratio for AVR has been reduced compared to a year ago.
AVR Yearly Shares OutstandingAVR Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 10M 20M 30M
AVR Yearly Total Debt VS Total AssetsAVR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of -32.74, we must say that AVR is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -32.74, AVR is not doing good in the industry: 90.96% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.02 indicates that AVR is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.02, AVR is in the better half of the industry, outperforming 71.28% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z -32.74
ROIC/WACCN/A
WACC8.77%
AVR Yearly LT Debt VS Equity VS FCFAVR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 0 20M -20M 40M -40M 60M -60M

2.3 Liquidity

A Current Ratio of 0.84 indicates that AVR may have some problems paying its short term obligations.
AVR has a worse Current ratio (0.84) than 90.96% of its industry peers.
A Quick Ratio of 0.80 indicates that AVR may have some problems paying its short term obligations.
With a Quick ratio value of 0.80, AVR is not doing good in the industry: 85.11% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.8
AVR Yearly Current Assets VS Current LiabilitesAVR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 20M 40M 60M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for AVR have decreased strongly by -65.77% in the last year.
The Revenue has decreased by -1.16% in the past year.
EPS 1Y (TTM)-65.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1.11%
Revenue 1Y (TTM)-1.16%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-44.21%

3.2 Future

Based on estimates for the next years, AVR will show a small growth in Earnings Per Share. The EPS will grow by 6.48% on average per year.
The Revenue is expected to grow by 142.95% on average over the next years. This is a very strong growth
EPS Next Y19.52%
EPS Next 2Y14.75%
EPS Next 3Y11.75%
EPS Next 5Y6.48%
Revenue Next Year5.99%
Revenue Next 2Y93.05%
Revenue Next 3Y36.88%
Revenue Next 5Y142.95%

3.3 Evolution

AVR Yearly Revenue VS EstimatesAVR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M 500M
AVR Yearly EPS VS EstimatesAVR Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 -0.5 -1 -1.5 -2 -2.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

AVR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AVR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AVR Price Earnings VS Forward Price EarningsAVR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AVR Per share dataAVR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.75%
EPS Next 3Y11.75%

More info and screens

0

5. Dividend

5.1 Amount

AVR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ANTERIS TECHNOLOGIES GLOBAL

NASDAQ:AVR (12/5/2025, 8:04:01 PM)

After market: 4.67 0 (0%)

4.67

+0.13 (+2.86%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-12 2025-11-12/amc
Earnings (Next)03-09 2026-03-09
Inst Owners56.99%
Inst Owner Change34.64%
Ins Owners0.19%
Ins Owner Change0%
Market Cap192.40M
Revenue(TTM)2.14M
Net Income(TTM)-83.94M
Analysts80
Price Target16.83 (260.39%)
Short Float %3.1%
Short Ratio5.51
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-7.22%
Min EPS beat(2)-7.67%
Max EPS beat(2)-6.76%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)14.28%
Min Revenue beat(2)6.19%
Max Revenue beat(2)22.38%
Revenue beat(4)3
Avg Revenue beat(4)4.73%
Min Revenue beat(4)-27.62%
Max Revenue beat(4)22.38%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-87.1%
Revenue NQ rev (3m)-87.1%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 89.95
P/FCF N/A
P/OCF N/A
P/B 52.03
P/tB 53.03
EV/EBITDA N/A
EPS(TTM)-2.34
EYN/A
EPS(NY)-2.01
Fwd EYN/A
FCF(TTM)-1.92
FCFYN/A
OCF(TTM)-1.88
OCFYN/A
SpS0.05
BVpS0.09
TBVpS0.09
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -440.09%
ROE -2269.93%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 67.94%
FCFM N/A
ROA(3y)-145.5%
ROA(5y)N/A
ROE(3y)-232.78%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.11
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 116.32%
Cap/Sales 89.62%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.84
Quick Ratio 0.8
Altman-Z -32.74
F-Score2
WACC8.77%
ROIC/WACCN/A
Cap/Depr(3y)191.13%
Cap/Depr(5y)N/A
Cap/Sales(3y)74.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-65.77%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1.11%
EPS Next Y19.52%
EPS Next 2Y14.75%
EPS Next 3Y11.75%
EPS Next 5Y6.48%
Revenue 1Y (TTM)-1.16%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-44.21%
Revenue Next Year5.99%
Revenue Next 2Y93.05%
Revenue Next 3Y36.88%
Revenue Next 5Y142.95%
EBIT growth 1Y-64.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-11.82%
EBIT Next 3Y-0.71%
EBIT Next 5Y18.6%
FCF growth 1Y-71.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-76.84%
OCF growth 3YN/A
OCF growth 5YN/A

ANTERIS TECHNOLOGIES GLOBAL / AVR FAQ

What is the ChartMill fundamental rating of ANTERIS TECHNOLOGIES GLOBAL (AVR) stock?

ChartMill assigns a fundamental rating of 2 / 10 to AVR.


What is the valuation status for AVR stock?

ChartMill assigns a valuation rating of 0 / 10 to ANTERIS TECHNOLOGIES GLOBAL (AVR). This can be considered as Overvalued.


What is the profitability of AVR stock?

ANTERIS TECHNOLOGIES GLOBAL (AVR) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for AVR stock?

The Earnings per Share (EPS) of ANTERIS TECHNOLOGIES GLOBAL (AVR) is expected to grow by 19.52% in the next year.